IMG_1584.jpg
+2 more
explain in each language with pathogenesis of each treatment how its acting in detail
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
I now have excellent source material. Let me compile a thorough, bilingual (English + Hindi) explanation of each drug's pathogenesis-based mechanism.
Management of AUB - Drug Mechanisms: Detailed Pathogenesis-Based Explanation
(Notes from Marrow Gynaecology v6.0, 2024 - your images)
AUB का Pathogenesis (Why bleeding happens?)
Normal menstruation: Estrogen endometrium ko proliferate karta hai → Progesterone aake stabilize karta hai → Progesterone withdraw hota hai → Orderly, controlled shedding with spiral arteriolar vasoconstriction → limited bleeding.
AUB (Anovulatory): Estrogen alone endometrium ko proliferate karta hai, progesterone nahi aata → endometrium thick hota rehta hai → irregularly shed hota hai without vasoconstriction → uncontrolled, heavy bleeding.
- Goldman-Cecil Medicine: "In anovulatory women, estrogen stimulates the endometrium unopposed by progesterone. The endometrium proliferates, becomes thicker, and may shed irregularly... anovulatory bleeding tends to be uncontrolled in both amount and duration."
1. TRANEXAMIC ACID (Antifibrinolytic)
English - Mechanism & Pathogenesis:
Why bleeding is heavy in AUB:
In AUB, the endometrial tissue has increased local fibrinolytic activity. Plasminogen activators (tPA) are upregulated in the endometrium → Plasminogen → Plasmin → breaks down fibrin clots → clots cannot hold → excessive, prolonged bleeding.
How Tranexamic Acid works:
- Tranexamic acid is a synthetic lysine analogue
- It competitively binds to the lysine-binding sites on plasminogen and plasmin
- This blocks plasminogen from binding to fibrin
- Result: Plasminogen cannot be activated to plasmin → fibrinolysis is inhibited → fibrin clots remain intact → bleeding is controlled
- It is 10x more potent than aminocaproic acid (Lippincott Pharmacology)
- Reduces AUB by 50%
- Dose: 1g (1000mg) thrice daily × 3-4 days (orally)
- FDA-approved for ovulatory AUB
- Well tolerated in cyclical bleeding with normal-size uterus
- Side effect: risk of intravascular thrombosis (use with caution)
Hindi mein:
AUB mein endometrium mein fibrinolysis badh jaati hai - matlab jo blood clots bante hain woh toot jaate hain jaldi. Plasminogen → Plasmin banta hai → yeh fibrin ko tod deta hai → clot nahi tikta → zyada bleeding hoti hai.
Tranexamic acid plasminogen ke lysine-binding site se chipak jaata hai → plasmin nahi banta → clot toot nahi paata → bleeding ruk jaati hai.
Yaad karo: "Fibrin ka raksha karta hai" - 50% tak bleeding kam karta hai.
2. MEFENAMIC ACID (NSAID - Prostaglandin Synthetase Inhibitor)
English - Mechanism & Pathogenesis:
Why prostaglandins cause AUB:
In AUB-E (Endometrial causes), there is an imbalance in prostaglandin ratio:
- PGE₂ (vasodilator) and PGI₂ (prostacyclin - vasodilator + inhibits platelet aggregation) are increased
- PGF₂α (vasoconstrictor) and TXA₂ (thromboxane - vasoconstrictor + platelet aggregation) are relatively decreased
- Net effect: vasodilation + impaired platelet clumping → excess bleeding
- Also, prostaglandins → reduce vessel contraction in the endometrium
How Mefenamic Acid works:
- It is a prostaglandin synthetase inhibitor (COX inhibitor)
- Blocks COX-1 and COX-2 → inhibits arachidonic acid conversion to prostaglandins
- Specifically blocks prostaglandin receptors (as noted in your image)
- Result: ↓ PGE₂, ↑ PGF₂α relative ratio → vasoconstriction restored → platelet aggregation improves → bleeding decreases
- Also useful in dysmenorrhoea (reduces uterine cramps caused by PGF₂α excess)
- Dose: 500 mg thrice daily
- NOT used as first-line drug alone; used with tranexamic acid
- Reduces blood loss 20-50% in ovulatory AUB
Hindi mein:
AUB mein prostaglandin ka balance bigad jaata hai - vasodilator PGE₂ zyada hota hai, vasoconstrictor PGF₂α kam hota hai → blood vessels dilated rehte hain → bleeding control nahi hoti.
Mefenamic acid COX enzyme block karta hai → prostaglandin nahi banta → balance restore hota hai → vessel constriction hoti hai → bleeding kam hoti hai.
Yaad karo: "Prostaglandin ka dushman" - AUB + dysmenorrhoea dono mein kaam aata hai.
3. ETHAMSYLATE (Capillary stabilizer)
English:
Mechanism:
- Reduces capillary fragility and permeability
- Promotes platelet adhesion and aggregation at sites of capillary damage
- Does NOT affect coagulation cascade directly
- Acts on prostaglandin metabolism (reduces PGI₂ - prostacyclin, which normally inhibits platelet aggregation)
Important note from your notes: "NOT effective in management of AUB" - its role is minimal/controversial in AUB management. It is noted to reduce capillary fragility but lacks strong evidence for AUB.
Hindi mein:
Ethamsylate capillary ki deewar strong karta hai - lekin AUB ke treatment mein effective nahi hai. Exams ke liye: "capillary fragility ↓ karta hai, but AUB mein use nahi karte."
4. OCPs - ORAL CONTRACEPTIVE PILLS (Estrogen + Progesterone)
English - Mechanism & Pathogenesis:
Why OCPs work in AUB:
Dual mechanism - your notes explain it perfectly:
A) Endometrial Stabilization (Direct Action):
- In anovulatory AUB: endometrium is proliferating under estrogen alone → unstable, shed irregularly
- OCP provides both Estrogen + Progesterone together
- Estrogen repairs and stabilizes the endometrial lining (stops acute breakdown)
- Progesterone converts the proliferative endometrium to secretory endometrium → organized, stable lining
- When OCP is stopped (progesterone withdrawal) → orderly, controlled, limited shedding → predictable, reduced bleeding
- Result: ↓ bleeding by ~50%, regularizes cycles
B) HPO Axis Suppression (Indirect Action):
- Combined E+P → negative feedback on hypothalamus and pituitary
- ↓ GnRH → ↓ LH + FSH secretion
- No LH surge → anovulation → no estrogen peak → thin, stable endometrium
- This also provides contraceptive benefit + ovarian suppression
Dosing in AUB (from your notes):
- Hb < 10 g/dL (severe anaemia): Give OCP continuously for 3 months (no break - to prevent any bleeding during recovery)
- Hb ≥ 10 g/dL: Give OCP 3 weeks on → 1 week off × 3 cycles (standard cycling)
- For contraceptive benefit: Start between D1-D5 of cycle → 21 days → progesterone withdrawal → withdrawal bleed → repeat
Advantages:
- Controls blood loss
- Regularises cycles - DOC (Drug of Choice) for regularising cycles = OCP
- Contraceptive benefit
- Suppression of ovaries
Pack: 21 tablets (21 days active)
Hindi mein:
AUB mein endometrium unstable hota hai kyunki sirf estrogen kaam kar raha hota hai - progesterone nahi hota. OCP dono deta hai:
- Estrogen → endometrium ki repair karta hai
- Progesterone → endometrium ko stable/secretory banata hai → control shed hoti hai → bleeding kam hoti hai
Hypothalamus-Pituitary pe negative feedback → LH/FSH kam hota hai → anovulation → contraception + ovarian suppression.
Yaad karo: "Stabil karo → Shed karo - controlled tarike se"
Dose:
- Hb < 10 → 3 mahine lagaataar (tak ki anaemia thik ho)
- Hb ≥ 10 → 3 hafte OCP, 1 hafte chhod, 3 cycles
5. PROGESTERONE (alone)
English - Mechanism & Pathogenesis:
Why progesterone alone works:
- In anovulatory AUB: the problem is unopposed estrogen → endometrium keeps proliferating
- Giving exogenous progesterone mimics the luteal phase
- It converts the proliferative (estrogenised) endometrium into a secretory endometrium
- Stabilizes endometrial stroma and glands
- When withdrawn → orderly, synchronized shedding with vasoconstriction → controlled, limited bleeding
- Also useful in perimenopausal/older patients where OCPs may be less preferred (no estrogen component = less thrombotic risk)
Key physiology (from Swanson's Family Medicine): "Sloughing of the endometrium does not occur unless progesterone withdrawal takes place. When progesterone is withdrawn, the tissue breakdown is orderly and progressive. Bleeding is limited in both amount and duration by spiral arteriolar vasoconstriction. Menstrual shedding is simultaneous in all endometrial segments."
Hindi mein:
Anovulatory AUB ka root cause hai "Progesterone nahi hai" → Endometrium sirf estrogen se proliferate karta rehta hai → uncontrolled shedding.
Progesterone dene se:
→ Endometrium secretory phase mein aata hai (stable ho jaata hai)
→ Jab band karo → controlled withdrawal bleed hoti hai - spiral arteries vasoconstrict karti hain → limited, predictable bleeding
Yaad karo: "Jis ki kami thi, wahi dedo"
Quick Summary Table
| Drug | Target | Mechanism | Reduces Bleeding By |
|---|---|---|---|
| Tranexamic acid | Fibrinolysis | Blocks plasminogen → no plasmin → fibrin preserved | ~50% |
| Mefenamic acid | Prostaglandins | COX inhibitor → ↓ PGE₂ vasodilation → vasoconstriction ↑ | 20-50% |
| Ethamsylate | Capillaries | ↓ Capillary fragility | Not effective in AUB |
| OCP (E+P) | Endometrium + HPO axis | Stabilizes endometrium + ↓LH/FSH → anovulation | ~50% |
| Progesterone | Endometrium | Converts proliferative → secretory → orderly shedding | Significant |
Exam points to remember:
- DOC for regularising cycles = OCP
- Tranexamic acid = antifibrinolytic, 50% reduction, 1g TDS × 3-4 days
- Mefenamic acid = NOT first-line alone; used WITH tranexamic acid; for AUB-E + dysmenorrhoea
- Ethamsylate = NOT effective in AUB (just know this negative point)
- Progesterone alone = preferred in perimenopausal/older/obese patients (no estrogen = no thrombosis risk)
- OCP Hb < 10 = continuous 3 months; Hb ≥ 10 = 3 weeks on/1 week off × 3 cycles
This is a shared conversation. Sign in to Orris to start your own chat.